Search details
1.
Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg?
Br J Cancer
; 127(3): 383-393, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35264788
2.
Longitudinal liquid biopsy anticipates hyperprogression and early death in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors.
Br J Cancer
; 127(11): 2034-2042, 2022 11.
Article
in English
| MEDLINE | ID: mdl-36175621
3.
Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancer.
Br J Cancer
; 123(1): 81-91, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32376889
4.
LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung Cancer.
Int J Mol Sci
; 20(8)2019 Apr 16.
Article
in English
| MEDLINE | ID: mdl-30995715
5.
Detection of Loss of Heterozygosity in cfDNA of Advanced EGFR- or KRAS-Mutated Non-Small-Cell Lung Cancer Patients.
Int J Mol Sci
; 21(1)2019 Dec 20.
Article
in English
| MEDLINE | ID: mdl-31861832
6.
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience.
Oncol Ther
; 12(1): 73-95, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38200361
7.
Metabolic classification of non-small cell lung cancer patient-derived xenografts by a digital pathology approach: A pilot study.
Front Oncol
; 13: 1070505, 2023.
Article
in English
| MEDLINE | ID: mdl-36925926
8.
Diagnostic accuracy of circulating free DNA testing for the detection of KRAS mutations in non-small cell lung cancer: A systematic review and meta-analysis.
Front Genet
; 13: 1015161, 2022.
Article
in English
| MEDLINE | ID: mdl-36386815
9.
EGFR T790M testing through repeated liquid biopsy over time: a real-world multicentric retrospective experience.
J Thorac Dis
; 14(9): 3364-3375, 2022 Sep.
Article
in English
| MEDLINE | ID: mdl-36245580
10.
Implementation of Next Generation Sequencing-Based Liquid Biopsy for Clinical Molecular Diagnostics in Non-Small Cell Lung Cancer (NSCLC) Patients.
Diagnostics (Basel)
; 11(8)2021 Aug 13.
Article
in English
| MEDLINE | ID: mdl-34441402
11.
ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA Analysis.
Front Oncol
; 11: 625636, 2021.
Article
in English
| MEDLINE | ID: mdl-33777770
12.
Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome.
Transl Lung Cancer Res
; 10(1): 202-220, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-33569305
13.
Detection of Low-Frequency KRAS Mutations in cfDNA From EGFR-Mutated NSCLC Patients After First-Line EGFR Tyrosine Kinase Inhibitors.
Front Oncol
; 10: 607840, 2020.
Article
in English
| MEDLINE | ID: mdl-33520716
14.
In situ Metabolic Profiling of Ovarian Cancer Tumor Xenografts: A Digital Pathology Approach.
Front Oncol
; 10: 1277, 2020.
Article
in English
| MEDLINE | ID: mdl-32974128
15.
Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non-small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy.
Clin Lung Cancer
; 21(1): 1-14.e3, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31601525
16.
LKB1/AMPK Pathway and Drug Response in Cancer: A Therapeutic Perspective.
Oxid Med Cell Longev
; 2019: 8730816, 2019.
Article
in English
| MEDLINE | ID: mdl-31781355
17.
Involvement of NADPH Oxidase 1 in Liver Kinase B1-Mediated Effects on Tumor Angiogenesis and Growth.
Front Oncol
; 8: 195, 2018.
Article
in English
| MEDLINE | ID: mdl-29915721
18.
Metformin Enhances Cisplatin-Induced Apoptosis and Prevents Resistance to Cisplatin in Co-mutated KRAS/LKB1 NSCLC.
J Thorac Oncol
; 13(11): 1692-1704, 2018 11.
Article
in English
| MEDLINE | ID: mdl-30149143
19.
Therapeutic concentrations of digitoxin inhibit endothelial focal adhesion kinase and angiogenesis induced by different growth factors.
Br J Pharmacol
; 174(18): 3094-3106, 2017 Sep.
Article
in English
| MEDLINE | ID: mdl-28688145
20.
LKB1 Expression Correlates with Increased Survival in Patients with Advanced Non-Small Cell Lung Cancer Treated with Chemotherapy and Bevacizumab.
Clin Cancer Res
; 23(13): 3316-3324, 2017 07 01.
Article
in English
| MEDLINE | ID: mdl-28119362